Evidence map›Paper›PMID 30150716›Full record

ArticleNature medicine2018

Regional variation limits applications of healthy gut microbiome reference ranges and disease models.

Yan He, Wei Wu, Hui-Min Zheng, Pan Li, Daniel McDonald, Hua-Fang Sheng, Mu-Xuan Chen, Zi-Hui Chen, Gui-Yuan Ji, Zhong-Dai-Xi Zheng and 14 more

Erratum issued 3 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 3 registered trials, which are not on this map. Cited by 521 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
521citing papers in PubMed, 12 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03990753 unknown statusnot on this mapstarted 2019, after this paper: background citation

Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901): A Prospective Multicenter Study

TypeobservationalSponsorNanfang Hospital, Southern Medical UniversityRan2019 to 2022Enrolled1,000ConditionsCompensated CirrhosisArmsesophagogastroduodenoscopy
NCT05628987 unknown statusnot on this mapstarted 2023, after this paper: background citation

The Association of Gut Microbiota and Spermatogenic Dysfunction

TypeobservationalSponsorZhujiang HospitalRan2023 to 2025Enrolled306ConditionsInfertility, Male, Azoospermia, Oligozoospermia, AsthenozoospermiaArmsno intervention
NCT05638269 unknown statusnot on this mapstarted 2022, after this paper: background citation

A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China

TypeobservationalSponsorZhujiang HospitalRan2022 to 2025Enrolled12,000ConditionsEssential Hypertension, Liver Cancer, Nasopharyngeal Cancer, Pancreatic CancerArmsno intervention
3 · Its place in the literature

Who cites it

521 citing papers in PubMed, 12 syntheses or guidelines pooled it.

  1. Pooled it
  2. Probiotic Supplementation and Bone Health Parameters in Adults: A Systematic Review and Meta-Analysis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Review
  15. Article
  16. Comparative analysis of gut microbiota in incident and prevalent peritoneal dialysis patients with peritoneal fibrosis, correlations with peritoneal equilibration test data in the peritoneal fibrosis cohort.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
    Article
  17. Review
  18. Review
  19. Review
  20. Review

461 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Yan He *Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Wei Wu *Department of Environmental Health, School of Public Health, Southern Medical University, Guangzhou, China.
Hui-Min Zheng *Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Pan Li *Division of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Daniel McDonaldDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.
Hua-Fang ShengDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Mu-Xuan ChenDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zi-Hui ChenGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
Gui-Yuan JiGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
Zhong-Dai-Xi ZhengDepartment of Environmental Health, School of Public Health, Southern Medical University, Guangzhou, China.
Prabhakar MujagondGut Infection and Inflammation Biology Lab, UNESCO-Regional Center for Biotechnology, NCR Biotech Science Cluster, Faridabad, India.
Xiao-Jiao ChenDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Zu-Hua RongDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Peng ChenDepartment of Pathophysiology, Southern Medical University, Guangzhou, China.
Li-Yi LyuShenzhen Fun-Poo Biotech Co., Ltd., Shenzhen, China.
Xian WangShenzhen Fun-Poo Biotech Co., Ltd., Shenzhen, China.
Chong-Bin WuShenzhen Fun-Poo Biotech Co., Ltd., Shenzhen, China.
Nan YuDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Yan-Jun XuGuangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
Jia YinDepartment of Neurology, NanFang Hospital, Southern Medical University, Guangzhou, China.
Jeroen RaesDepartment of Microbiology and Immunology, KU Leuven-University of Leuven, Leuven, Belgium.
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0002-0975-9019
Wen-Jun MaGuangdong Provincial Institute of Public Health, Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China. mawj@gdiph.org.cn.
Hong-Wei ZhouDivision of Laboratory Medicine, Zhujiang Hospital, Southern Medical University, Guangzhou, China. biodegradation@gmail.com.ORCID http://orcid.org/0000-0003-2472-8541

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysbiosis, departure of the gut microbiome from a healthy state, has been suggested to be a powerful biomarker of disease incidence and progression

Indexed as

PhylogeographyChinaFemaleGastrointestinal MicrobiomeHost-Pathogen InteractionsHumansMaleMetabolic DiseasesPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.